MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta‐analysis | Synapse
January 14, 2019
MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta‐analysis
Key Points
Key points are not available for this paper at this time.
Abstract
3 Technical Efficacy Stage: 2 J. Magn. Reson. Imaging 2019;50:560-572.